The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Hypertrophic cardiomyopathy
Publications
Hypertrophic Cardiomyopathy After a Single Dose of Dexamethasone in a Preterm Infant.
Pediatrics and neonatology 2015 Aug;56;268-70 — 2015 Aug — 268-70
Left ventricular hypertrophy with outflow tract obstruction-a complication of dexamethasone treatment for subglottic stenosis.
International journal of pediatric otorhinolaryngology 2005 Feb;69;271-3 — 2005 Feb — 271-3
Miranda-Mallea J, Pérez-Verdú J, Gascó-Lacalle B, Sáez-Palacios JM, Fernández-Gilino C, Izquierdo-Macián I
Hypertrophic cardiomyopathy in preterm infants treated with dexamethasone.
European journal of pediatrics 1997 May;156;394-6 — 1997 May — 394-6
[Glucocorticoid-induced hypertrophic cardiomyopathy in premature infants: apropos of 4 cases].
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 1997 Feb;4;152-7 — 1997 Feb — 152-7